Net Cash Provided by (Used in) Financing Activities in USD of Moderna, Inc. from 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Moderna, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2016 to Q1 2025.
  • Moderna, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $4,000,000, a 71% decline year-over-year.
  • Moderna, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $56,000,000.
  • Moderna, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,377,000,000, a 60% increase from 2022.
  • Moderna, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3,448,000,000, a 295% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Moderna, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,000,000 -$10,000,000 -71% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $14,000,000 +$556,000,000 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $542,000,000 +$100,000,000 +16% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $642,000,000 -$668,000,000 -2569% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $26,000,000 -$552,000,000 -96% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $578,000,000 +$577,707,000 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $293,000* -$549,702,000 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $549,995,000 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1

Moderna, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $56,000,000 +$1,433,000,000 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $1,377,000,000 +$2,071,000,000 +60% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $3,448,000,000 -$2,575,000,000 -295% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $873,000,000 -$2,906,000,000 -143% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $2,033,000,000 +$1,981,000,000 +3810% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $52,000,000 -$1,174,842,000 -96% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $1,226,842,000 +$1,226,674,000 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $168,000* -$472,742,000 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $472,910,000 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.